大黄素抑制胰腺癌裸鼠原位移植瘤的实验研究(3)
 |
| 第1页 |
 |
| 第7页 |
参见附件(4876KB，7页)。
[5] Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation[J]. Trends Biochem Sci, 1997, 22(7): 251-256.
[6] Folkman J. Tumor angiogenesis: therapeutic implications[J]. N Engl J Med, 1971, 285(21): 1182-1186.
[7] Kaneshiro T, Morioka T, Inamine M, et al. Anthraquinone derivative emodin inhibits tumor-associated angiogenesis through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation[J]. Eur J Pharmacol, 2006, 28 553(1-3):46-53.
[8] Kimura Y, Sumiyoshi M, Taniguchi M, et al. Antitumor and antimetastatic actions of anthrone-C-glucoside, cassialoin isolated from Cassia garrettiana heartwood in colon 26-bearing mice[J]. Cancer Sci, 2008, 99(11): 2336-2348.
[9] Sugiura Y, Shimada H, Seeger R C, et al. Matrix metalloproteinases- 2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis[J]. Cancer Res, 1988, 58(10): 2209-2216.
[10] Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis[J]. Nat Cell Biol, 2000,2(10):737-744.
[11] Huang Q, Shen HM, Ong CN. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB[J]. Biochem Pharmacol, 2004, 68(2):361-371.
[12] Motzer R J, Michaelson M D, Redman B G, et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma[J]. J Clin Oncol, 2006, 24(1):16-24.
[13] Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma[J]. N Engl J Med. 2007, 356(2):125-134.
您现在查看是摘要介绍页，详见PDF附件(4876KB，7页)。